Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
Understanding the antibody response in HIV-1 infection is important to vaccine design. We have studied the antibody response to HIV-1 envelope at the molecular level and determined the characteristics of neutralizing and non-neutralizing antibodies. These antibodies were isolated from phage display...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1997
|
| _version_ | 1826272795916500992 |
|---|---|
| author | Parren, P Gauduin, M Koup, R Poignard, P Sattentau, Q Fisicaro, P Burton, DR |
| author_facet | Parren, P Gauduin, M Koup, R Poignard, P Sattentau, Q Fisicaro, P Burton, DR |
| author_sort | Parren, P |
| collection | OXFORD |
| description | Understanding the antibody response in HIV-1 infection is important to vaccine design. We have studied the antibody response to HIV-1 envelope at the molecular level and determined the characteristics of neutralizing and non-neutralizing antibodies. These antibodies were isolated from phage display libraries prepared from long-term seropositive asymptomatic individuals. The HIV-1 envelope is presented to the immune system in several antigenically distinct configurations: unprocessed gp160, gp120 and gp41 subunits and native envelope, each of which may be important in eliciting an antibody response in HIV-1 infection. The antibodies tested characteristically had poor affinities for native envelope as expressed on the surface of virions or infected cells, but had high affinities against non-native forms of HIV-1 envelope (viral debris). An exceptionally potent neutralizing antibody in contrast, bound native envelope with equivalent or somewhat higher affinity than this. This indicates that the antibody response in HIV-1 infection is principally elicited by viral debris rather than virions, and that these antibodies bind and neutralize viruses sub-optimally. Potential vaccines should be designed to elicit responses against native envelope. |
| first_indexed | 2024-03-06T22:18:14Z |
| format | Journal article |
| id | oxford-uuid:5425328d-38a6-47f3-9173-5a11344d78cc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:18:14Z |
| publishDate | 1997 |
| record_format | dspace |
| spelling | oxford-uuid:5425328d-38a6-47f3-9173-5a11344d78cc2022-03-26T16:35:54ZErratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5425328d-38a6-47f3-9173-5a11344d78ccEnglishSymplectic Elements at Oxford1997Parren, PGauduin, MKoup, RPoignard, PSattentau, QFisicaro, PBurton, DRUnderstanding the antibody response in HIV-1 infection is important to vaccine design. We have studied the antibody response to HIV-1 envelope at the molecular level and determined the characteristics of neutralizing and non-neutralizing antibodies. These antibodies were isolated from phage display libraries prepared from long-term seropositive asymptomatic individuals. The HIV-1 envelope is presented to the immune system in several antigenically distinct configurations: unprocessed gp160, gp120 and gp41 subunits and native envelope, each of which may be important in eliciting an antibody response in HIV-1 infection. The antibodies tested characteristically had poor affinities for native envelope as expressed on the surface of virions or infected cells, but had high affinities against non-native forms of HIV-1 envelope (viral debris). An exceptionally potent neutralizing antibody in contrast, bound native envelope with equivalent or somewhat higher affinity than this. This indicates that the antibody response in HIV-1 infection is principally elicited by viral debris rather than virions, and that these antibodies bind and neutralize viruses sub-optimally. Potential vaccines should be designed to elicit responses against native envelope. |
| spellingShingle | Parren, P Gauduin, M Koup, R Poignard, P Sattentau, Q Fisicaro, P Burton, DR Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title_full | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title_fullStr | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title_full_unstemmed | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title_short | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| title_sort | erratum to relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design |
| work_keys_str_mv | AT parrenp erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT gauduinm erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT koupr erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT poignardp erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT sattentauq erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT fisicarop erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign AT burtondr erratumtorelevanceoftheantibodyresponseagainsthumanimmunodeficiencyvirustype1envelopetovaccinedesign |